Rørvik J, Halvorsen O J, Albrektsen G, Haukaas S
Department of Radiology, Gade Institute, Norway.
Scand J Urol Nephrol. 1998 Apr;32(2):116-9. doi: 10.1080/003655998750014486.
To evaluate the efficacy of lymphangiography combined with fine needle aspiration biopsy and computer tomography (CT) for lymph node staging in clinically localized prostate cancer. Prospective evaluation of nodal involvement was carried out using standard bipedal lymphangiography combined with fine needle aspiration biopsy (FNAB) in 70 patients (aged 47 to 75 years, mean age 63 years) with apparently locally confined prostate cancer before intended radical prostatectomy. Sixty-four patients also underwent computer tomography. Seventeen withdrew the decision to undergo a radical prostatectomy, leaving 53 patients with pathologic examination of the lymph nodes eligible for analysis. Lymph node metastases were diagnosed in 8 patients (8/53 = 15.1%). Three were diagnosed preoperatively by FNAB, 3 peroperatively by lymph node dissection and frozen section biopsy and an additional 2 at the final pathologic assessment. The sensitivity, specificity, positive and negative predictive values for lymphangiography and lymphangiography combined with FNAB in predicting nodal disease, based on the analysis of the 53 patients with known pathologic results, were 0.63, 0.76, 0.31, 0.92 and 0.38, 1.00, 1.00, 0.90, respectively. The corresponding values for CT staging were 0.25, 0.98, 0.67 and 0.87, respectively. The efficacy of bipedal lymphangiography alone or combined with FNAB or CT alone for assessment of nodal metastases is too low to be worthwhile for lymph node staging in localized prostate cancer patients with expected low or intermediate probability of nodal disease.
评估淋巴管造影联合细针穿刺活检及计算机断层扫描(CT)在临床局限性前列腺癌淋巴结分期中的疗效。对70例(年龄47至75岁,平均年龄63岁)拟行根治性前列腺切除术、临床分期为局限性前列腺癌的患者,采用标准双侧淋巴管造影联合细针穿刺活检(FNAB)对淋巴结受累情况进行前瞻性评估。其中64例患者还接受了计算机断层扫描。17例患者撤销了根治性前列腺切除术的决定,剩余53例患者的淋巴结病理检查结果可供分析。8例患者(8/53 = 15.1%)被诊断为淋巴结转移。3例术前通过FNAB诊断,3例术中通过淋巴结清扫及冰冻切片活检诊断,另外2例在最终病理评估时诊断。基于对53例已知病理结果患者的分析,淋巴管造影及淋巴管造影联合FNAB预测淋巴结疾病的敏感性、特异性、阳性预测值和阴性预测值分别为0.63、0.76、0.31、0.92和0.38、1.00、1.00、0.90。CT分期的相应值分别为0.25、0.98、0.67和0.87。对于预期淋巴结转移概率低或中等的局限性前列腺癌患者,单独双侧淋巴管造影或联合FNAB或单独CT评估淋巴结转移的疗效过低,不值得用于淋巴结分期。